31
Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer
Condition(s):Malignant Solid TumourLast Updated:May 20, 2010Terminated
Vinorelbine: 519 Clinical Trials, Page 4 of 52
Hide Studies Not Open or Pending
32
Almonertinib Plus Metronomic Oral Vinorelbine
Condition(s):EGFR; NSCLC; Third-generation TKILast Updated:December 23, 2022Not yet recruiting
33
Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer
Condition(s):Breast Cancer; Pyrotinib; Breast Diseases; Vinorelbine; HER2-positive Breast CancerLast Updated:April 26, 2022Recruiting
34
GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA Trial
Condition(s):Non Small Cell Lung CancerLast Updated:December 18, 2014Unknown status
35
Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC
Condition(s):Metastatic Breast CancerLast Updated:November 23, 2021Recruiting
36
Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer
Condition(s):Advanced Non-Small Cell Lung CancerLast Updated:August 22, 2022Recruiting
37
Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria
Condition(s):Non-Small-Cell Lung Cancer; Breast CancerLast Updated:August 29, 2018Completed
38
Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer
Condition(s):Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube CancerLast Updated:February 18, 2015Completed
39
Vinorelbine/Carboplatin Versus Gemcitabine/Carboplatin in Metastatic Breast Cancer
Condition(s):Metastatic Breast CancerLast Updated:October 30, 2019Not yet recruiting
40
Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
Condition(s):Metastatic Breast CancerLast Updated:March 3, 2021Recruiting